info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Dural Arteriovenous Fistulas Treatment Companies

Dural arteriovenous fistulas (DAVFs) are abnormal connections between arteries and veins within the dura mater, the outermost layer of the brain covering. The treatment of DAVFs often involves a multidisciplinary approach, and various medical device companies provide products and solutions for their management. 

Dural arteriovenous fistulas Treatment Market

 


Latest Dural Arteriovenous Fistulas Treatment Companies Updates:


Cedars-Sinai Medical Center initiates a clinical trial This study investigates the safety and efficacy of a novel embolic device for treating DAVFs. The device aims to offer a minimally invasive option with potentially shorter recovery times compared to traditional surgery.


Mayo Clinic publishes research on flow diverter stents This study demonstrates the effectiveness of flow diverter stents in closing DAVFs, potentially providing an alternative to surgery for high-risk patients.


Acteon acquires FlowCardia This December 2023 deal strengthens Acteon's position in the neurovascular market by adding FlowCardia's expertise in DAVF treatment devices.MicroVention partners with University of California, San Francisco: This collaboration aims to develop and commercialize next-generation embolic materials for DAVF treatment, focusing on improved targeting and efficacy.


List of Dural Arteriovenous Fistulas Treatment Key companies in the market:



  • BD (U.S.)

  • Medtronic (U.S.)

  • B. Braun Melsungen AG (Germany)

  • Cook (U.S.)

  • Teleflex Incorporated (U.S.)

  • Fresenius Medical Care AG & Co. KGaA (Germany)

  • NxStage Medical, Inc.(U.S.)

  • Poly Medicure Limited


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.